Tremmel, Roman http://orcid.org/0000-0003-1564-0433
Zhou, Yitian
Schwab, Matthias http://orcid.org/0000-0002-9984-075X
Lauschke, Volker M. http://orcid.org/0000-0002-1140-6204
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (668353)
Article History
Received: 5 May 2023
Accepted: 29 August 2023
First Online: 8 September 2023
Competing interests
: V.M.L. is CEO and shareholder of HepaPredict AB. The remaining authors declare no competing interests.